In June of this year, the Federal Circuit panel in Ariosa Diagnostics, Inc. v. Sequenom, Inc. invalidated a patent on the grounds of patent-ineligible subject matter. 788 F.3d 1371 (Fed. Cir. 2015). While the case is one of...more
11/5/2015
/ Declaratory Rulings ,
DNA ,
En Banc Review ,
Life Sciences ,
Mootness ,
Myriad-Mayo ,
Patent Infringement ,
Patent Invalidity ,
Patent-Eligible Subject Matter ,
Patents ,
Petition For Rehearing ,
Preemption ,
Product of Nature Doctrine ,
Section 101
In This Bulletin:
- Just Moot It: Supreme Court in Already v. Nike Clarifies When a Covenant Not to Sue Can Kill a Declaratory Judgment Case
- Murky Waters: Post-Approval Regulatory Activities and the §...more
4/4/2013
/ Covenant Not to Sue ,
Food and Drug Administration (FDA) ,
Generic Drugs ,
Mootness ,
Nike ,
Pharmaceutical Industry ,
Public Performance Rights ,
Safe Harbors ,
SCOTUS ,
Standing ,
Trade Secrets ,
Trademarks ,
Transfer of Venue